C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 229/00 (2006.01) A61K 31/395 (2006.01)
Patent
CA 2570694
The present invention relates to inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor MR, and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-.beta. hydroxyl steroid dehydrogenase type 1 and/or diseases associated with aldosterone excess.
La présente invention concerne des inhibiteurs de la 11-ß hydroxystéroïde déshydrogénase de type 1, des antagonistes du récepteur des minéralocorticoïdes (MR) et des compositions pharmaceutiques de ces derniers. Les composés selon l'invention peuvent être utiles dans le traitement de diverses maladies associées à l'expression ou à l'activité de la 11-ß hydroxystéroïde déshydrogénase de type 1 et/ou de maladies associées à un excès d'aldostérone.
He Chunhong
Metcalf Brian
Xu Meizhong
Zhang Colin
Zhuo Jincong
Incyte Corporation
Smart & Biggar
LandOfFree
Amido compounds and their use as pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amido compounds and their use as pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amido compounds and their use as pharmaceuticals will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1896964